|
Volumn 66, Issue 6, 1996, Pages 954-961
|
Contraceptive efficacy, pharmacokinetics, and safety of Annuelle® biodegradable norethindrone pellet implants
a a a a a a |
Author keywords
adverse events; contraception; hormone levels; implants; Norethindrone
|
Indexed keywords
ANNUELLE;
ESTRADIOL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NORETHISTERONE;
PROGESTERONE;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTRACEPTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG IMPLANT;
DRUG SAFETY;
ESTRADIOL BLOOD LEVEL;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
MULTICENTER STUDY;
NORMAL HUMAN;
PRIORITY JOURNAL;
PROGESTERONE BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
VAGINA BLEEDING;
|
EID: 0030448536
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(16)58689-0 Document Type: Article |
Times cited : (8)
|
References (9)
|